“For an effective transfer of genetic material carried by a plasmid, “BioShuttle” technology is an appropriate tool” the results demonstrated by a study.
The beginning of cancer can be described as a genetic accident. More than 200 genes play a role in the generation of cancer. The genetic malfunction can be compensated by introducing one or more therapeutic genes in to the target cells for the treatment of genetic diseases. For the efficient transport of therapeutic genetic material in to the nucleus of the target cells are the direct passage through the nuclear envelope in to the nucleus and the quick transport across the plasma membrane in to the cytosol. To overcome these barriers numerous delivery systems have been developed such as viral vectors, ultrasound and non-viral peptide based carrier systems.
continue reading BioShuttle-A New Technology for Mediated Plasmid Transfer
